BPC 157 erectile dysfunction: What the evidence and user experiences actually show FDA issued its first warning letter to a dispenser (a medical spa) for violating the Drug Supply Chain Security Act (DSCSA), including failing to source products from authorized trading partners and FDA to weigh easing limits on unproven peptides promoted by RFK Jr. BPC 157: Experimental Peptide Creates Risk for Athletes FDA Finds Sterility Lapses at Compounding Facilities The Partnership for Safe Medicines posted on the topic LinkedIn